...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: what comes next for Zen?

Can we expect an offer in the near future/this year?

Is Pfe sterring the ship now?

When might we see some news?

getting restless :)

 

glta

Share
New Message
Please login to post a reply